VRTX dropped VX-500, the ‘second-generation’ PI behind Telaprevir. The program for VX-813 (which had been the follow-up to the follow-up to Telaprevir), is still active. See announcement in the next post.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”